Activated Macrophage Mediated Cytotoxicity for Transformed Target Cells

  • John B. HibbsJr.
  • Donald L. Granger
  • James L. Cook
  • Andrew M. LewisJr.
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 146)


The biochemical mechanisms that induce target cell lysis in cell mediated cytotoxicity systems—cytotoxic T-lymphocytes, natural killer cells, natural cytotoxicity cells, antibody dependent cell mediated cytotoxicity systems, and cytotoxic activated macrophages—are unknown. Identification of the biochemical effector mechanism(s) utilized by activated macrophages to induce stasis and lysis of transformed target cells is complicated by the large armamentarium of potential cytotoxic effector molecules that can be elaborated by macrophages. Evidence of activated macrophage mediated target cell cytotoxicity-cytostasis and cytolysis—has been observed and documented most extensively with techniques suitable for analysis of biologic phenomena at the cellular level. Observation at the cellular level has not provided evidence that demonstrates, in a definitive way, which potential effector molecules, among the many elaborated by macrophages, are relevant to the destruction of nucleated mammalian cells or to control of abnormal proliferation of mammalian cells in vivo.


Target Cell L1210 Cell Mitochondrial Respiration Terminal Electron Acceptor Mycobacterium Bovis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Granger, D.L., Taintor, R.R., Cook, J.L., and J.B. Hibbs, Jr. Injury of neoplatic cells by murine macrophages leads to inhibition of mitochondrial respiration. J. Clin. Invest. 65:357 (1980).PubMedCrossRefGoogle Scholar
  2. 2.
    Hibbs, J.B., Jr., Lambert, L.H., Jr., and J.S. Remington. Control of carcinogenesis: A possible role for the activated macrophage. Science 177:998 (1972).PubMedCrossRefGoogle Scholar
  3. 3.
    Meitzer, M.S., Tucker, R.W., and A.C. Breur. Interaction of BCG-activated macrophages with neoplastic and nonneoplastic cell lines - in vitro: Cinemicrographic analysis. Cell. Immunol. 17:30 (1975).CrossRefGoogle Scholar
  4. 4.
    Keller, R. Cytostatic elimination of syngeneic rat tumor cells in vitro by nonspecifically activated macrophages. J. Exp. Med. 138:625 (1973).PubMedCrossRefGoogle Scholar
  5. 5.
    Krahenbuhl, J.L., and J.S. Remington. The role of activated marcophages in specific and nonspecific cytostasis of tumor cells. J. Immunol. 113:507 (1974).PubMedGoogle Scholar
  6. 6.
    Krahenbuhl, J.L. Effects of activated macrophages of tumor target cells in discrete phases of the cell cycle. Cancer Res. 40:4622 (1980).PubMedGoogle Scholar
  7. 7.
    Kaplan, A.M., Brown, J., Collins, J.M., Morahan, P.S., and M.J. Snodgrass. Mechanism of macrophage-mediated tumor cell cytotoxicity. J. Immunol. 121:1781 (1978).PubMedGoogle Scholar
  8. 8.
    Skipper, H.E., Schabel, F.M., Jr., and W.S. Wilcox. Experimental evaluation of potential anticancer agents. XIII. On the criteria and kinetics associated with “curability” of experimental leukemia. Cancer Chemother. Rep. 35:1 (1964).PubMedGoogle Scholar
  9. 9.
    Hibbs, J.B., Jr., Lambert, L.H., Jr., and J.S. Remington. Resistance to murine tumors conferred by chronic infection with intracellular protozoa. Toxoplasma gondii and Bemitia jellisonii. J. Infect. Dis. 124:587 (1971).PubMedCrossRefGoogle Scholar
  10. 10.
    Lehninger, A.L. Biochemistry. Worth Publishers, Inc., New York, p. 387 (1975).Google Scholar
  11. 11.
    Slater, E.C. Application of inhbitors and uncouplers for study of oxidastive phosphorylation. Methods Enzymol. 10: 48 (1967).CrossRefGoogle Scholar
  12. 12.
    Racker, E. Lecture 4: The coupling device: J “A New Look at Mechanisms in Bioenergetics,” Academic Press, Inc., New York, p. 67 (1976).Google Scholar
  13. 13.
    Granger, D.L., and J.B. Hibbs, Jr. Recovery from injury incurred by leukemia cells in contact with activated macrophages. Fed. Proc. 40:761 (1981).Google Scholar
  14. 14.
    Lewis, A.M., Jr., and J.L. Cook. Presence of allograft- rejection resistance in simian virus 40-transformed hamster cells and its possible role in tumor development. Proc. Natl. Acad. Sci. USA 77:2889 (1980)Google Scholar
  15. 15.
    Butel, J.S., Tenethia, S.S., and J.L. Melnick. Oncogenicity and cell transformation by papovavirus SV40: The role the viral genome. Adv. in Cancer Res. 15:1 (1972).CrossRefGoogle Scholar
  16. 16.
    Duncan, W.R., and J.W. Streilein. Analysis of the major histocompatibility complex in Syrian hamsters. Transplantation 25: 12 (1978).PubMedCrossRefGoogle Scholar
  17. 17.
    Cook J.L., Hibbs, J.B., Jr., and A.M. Lewis, Jr. Resistance of simian virus 40-transformed hamster cells to the cytolytic, effect of activated macrophages: A possible factor in species- specific viral oncogenicity. Proc. Natl. Acad. Sci. USA 77:6773 (1980).PubMedCrossRefGoogle Scholar
  18. 18.
    Zbar, B., Wepsic, H.T., Borsos, T., and H.J. Rapp. Tumor graft rejection in sjmgeneic guinea pigs: Evidence for a two-step mechanism. J. Nat. Cancer Inst. 44:473 (1970).PubMedGoogle Scholar
  19. 19.
    Hibbs, J.B., Jr. Macrophage nonimmunologic recognition: Target cell factors related to contact inhibition. Science 180:868 (1973).PubMedCrossRefGoogle Scholar
  20. 20.
    Hibbs, J.B., Jr., Chapman, H.A., Jr., and J.B. Weinberg. The macrophage as an antineoplastic surveillance cell: Biologic perspectives. J. Reticuloendothelial Soc. 24:549 (1978).Google Scholar
  21. 21.
    Hibbs, J.B., Jr. Heterocytolysis by macrophages activated by bacillus Calmette-Guerin: Lysosome exocytosis into tumor cells. Science 184:468 (1974).PubMedCrossRefGoogle Scholar
  22. 22.
    Bucana, C., Hoyer, L.C., Hobbs, B., Breesman, S., McDaniel, M., and M.G. Hanna. Morphological evidence for the translocation of lysosomal organelles from cytotoxic macrophages into the cytoplasm of tumor target cells. Cancer Res. 36:4444 (1976).PubMedGoogle Scholar
  23. 23.
    Otto, K. Cathespins Bi and B2. “Tissue Proteinases,” edited by A.J. Barrett and J.T. Dingle. North-Holland Publishing Co., Amsterdam, p. 1 (1971).Google Scholar
  24. 24.
    Adams, D.O. Effector mechanism of cytolytically activated macrophages. I. Secretion of neutral proteases and effect of protease inhibitors. J. Immunol. 124:286 (1980).PubMedGoogle Scholar
  25. 25.
    Hibbs, J.B., Jr., Taintor, R.R., Chapman, H.A., Jr., and J.B. Weinberg. Macrophage tumor cell killing: Influence of the local environment. Science 197:279 (1977).PubMedCrossRefGoogle Scholar
  26. 26.
    Chang, T.W., and H.N. Eisen. Effects of TLCK bn the activity of cytotoxic lymphocytes. J. Immunol. 124:1028 (1980).PubMedGoogle Scholar
  27. 27.
    Martz, E. Mechanism of specific tumor cell lysis by allo- immune T-lymphocytes: Resolution and characterization of discrete steps in the cellular interaction. Contemp. Top. Immunol. 7:301 (1977).CrossRefGoogle Scholar
  28. 28.
    Roder, JC., Argov, S., Klein, M., Petersson, C., Kiessling, R., Anderson, K., and M. Hansson. Target-effector cell interaction in the natural killer cell system. V. Energy requirements, membrane integrity, and the possible involvement of lysosomal enzymes. Immunology 40:107 (1980).PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1982

Authors and Affiliations

  • John B. HibbsJr.
    • 1
  • Donald L. Granger
    • 2
  • James L. Cook
    • 3
  • Andrew M. LewisJr.
    • 4
  1. 1.Veterans Administration Medical Center and Department of Medicine, Division of Infectious DiseasesUniversity of Utah School of MedicineSalt Lake CityUSA
  2. 2.Department of Physiological Chemistry, School of MedicineJohns Hopkins UniversityBaltimoreUSA
  3. 3.National Jewish Hospital and Research CenterDenverUSA
  4. 4.National Institute of Allergy and Infectious DiseasesNational Institutes of HealthBethesdaUSA

Personalised recommendations